SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Ariella who wrote (35)11/3/1998 11:42:00 AM
From: David Israel-Rosen  Read Replies (2) | Respond to of 1386
 
Dear Ariella:

1) PARS is selling at a Fraction of its True Value. If HU211 is what we think it is and it can be bought at a fraction of its value RX companies can easily be tempted.
2) As far as a take-over. Let me explain some realities:

a) No One control PARS !!! - there is no group that own let us say 10% of shares !!! As a fact members of this thread represent some of the largest groups of share holders !!!

b) If a Control group is to be formed - for example, Castle & Partner, Yosi, Ariella, and myself it will have (by default) an effective control of Pharmos.

c) Control Group goes to for example E. Liily and solicit its interest in purchasing Pars for $5 a share. Control group reaches an agreement with purchaser and agrees to tender its own shares

d) Control Group puts such an offer for a vote. Management and the board might recomend agianst offer, but I will bet the offer will pass and Pars will be sold.

e) We do not have a take-over but rather a Vote by share holders to sell the company.

f) You can call BTGC and you will find out that the situation there was the same.

3) Management can prevent such a move from happening by PUSHING the stock. Not by Hype but by agressively putting the information that they have out.

4) I do not know about you. But my investment in PARS is not doing that well at this time. While I am confident in the Future of the Company and intend to remain LONG as a long Term Investment I am not happy with the Performance of MGT and its PR efforts.

5) The access that you, me, and others have to Mgt is not a substitute for the Comapny allowing the PR agency to PUSH the stock.

6) Your arguement that pushing the stock to $2.5-3.00 will only be temporary is contradictary to your OWN View that there is VALUE here. I belive that if the street new the STORY it will reward the Stock accordingly.

7) Are people realy Feel GOOD with the Performance of the Stock or they just gave up on the ABILITY of MGT to Push the Stock Higher ?
People come up with all kind of rationals such as :
The Low Price gives me additional BUYING opportunities !!!

8) Let us be real - the role of the CEO is to enhance Shareholder value. A significant source of shareholder value is the stock price...

9) The stock price will determine for example the price that an HU211 partner will pay for new shares PARS issues (most likely) with any agreement.

10) If they issue 5 Million shares $1.75 of 2.5 Million shares to the New Partner @ $3.50 is Important !!!

11) Your feedback is welcomed

David